Table II.
Primary NSCLC | FF | FFF | P-value | Test |
---|---|---|---|---|
Number of lesions | 25 | 27 | ||
Pathology | ||||
Adenocarcinoma | 8 | 9 | 0.91 | χ2 |
Squamous cell | 2 | 3 | ||
Others | 0 | 0 | ||
Unknown | 15 | 15 | ||
Lesion texture | ||||
GGO | 3 | 1 | 0.53 | χ2 |
Part-solid | 3 | 4 | ||
Solid | 19 | 22 | ||
Tumor diameter | ||||
Mean (range) | 22.9 (0–51) | 24.0 (4–60) | 0.68 | Unpaired t |
T-Stage | ||||
T0 | 3 | 1 | 0.65 | χ2 |
T1A1 | 1 | 1 | ||
T1A2 | 12 | 12 | ||
T1A3 | 6 | 8 | ||
T1B | 1 | 1 | ||
T2A | 1 | 2 | ||
T2B | 1 | 2 |
NSCLC, non-small cell lung carcinoma; GGO, ground glass opacity.